Arcutis Biotherapeutics, Inc. (ARQT)
26.98
+0.67
(+2.55%)
USD |
NASDAQ |
Feb 24, 16:00
26.99
+0.01
(+0.04%)
After-Hours: 20:00
Arcutis Biotherapeutics Research and Development Expense (Quarterly) : 19.60M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| CorMedix, Inc. | 5.098M |
| ADMA Biologics, Inc. | 1.528M |
| ANI Pharmaceuticals, Inc. | 12.30M |
| Amicus Therapeutics, Inc. | 23.74M |
| Pacira Biosciences, Inc. | 25.97M |